Scientists have described a novel, yet benign bone-covered growth's characteristics for doctors, so patients don't receive ...

Multiple myeloma is the second most common blood cancer in the United States, and it is more common in men, with an estimated ...

Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same time. The material heats up under a magnetic field to destroy tumors, while ...

Patients with multiple myeloma often develop bone lesions resulting in skeletal-related events (SREs), such as spinal cord compression, vertebral collapse, pathologic fractures and bone pain. Bone ...

In a recently published study, researchers at Fox Chase Cancer Center revealed for the first time that cancer cells can evade anti-cancer drugs by entering and surviving within bone marrow fibroblasts ...

Bone cancer in the leg, while relatively uncommon, presents with specific warning signs that warrant immediate medical attention. Understanding these symptoms enables individuals to seek prompt ...

Australian researchers have discovered a targeted approach to treating myelofibrosis, a rare and serious blood cancer, beyond symptom management. The report published in the journal ‘Blood’ on Monday ...